Eli Lilly is launching a challenge encouraging individuals and teams across the US to develop digital health solutions aimed at transforming inflammatory bowel disease (IBD) care.<
Experts in digital health have published guidance on use of artificial intelligence (AI) in healthcare, warning that the technology may not be able to keep up with how medicines are used in
Thousands of patients at risk of type 2 diabetes are to receive digital support to help prevent them developing the condition as part of an expansion of these schemes on England’s NHS.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.